| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $43.8M | $40.7M | $33.3M |
| YoY Revenue Growth % | +7.6% | +22.2% | — |
| Gross Profit | -$44.7M | -$42.1M | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$57.5M | -$47.5M | -$80.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | $22.6M | -$69.9M | -$113.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.5M | $12.9M | -$15.7M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $3.5M | $12.9M | -$15.7M |
| FCF Margin % | 8.0% | 31.7% | -47.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $50.4M | $77.4M | — |
| Total Debt (Short + Long Term) | $156.6M | $333.7M | — |
| Total Stockholders' Equity | -$36.1M | -$182.5M | — |